REHABILITATION INSTITUTE OF CHICAGO
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1954-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.ric.org/
Clinical Trials
164
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (145 trials with phase data)• Click on a phase to view related trials
WIM Exosuit Wearable Soft Robot for Enhancing Walking Activity
- Conditions
- StrokeHealthy
- First Posted Date
- 2025-07-11
- Last Posted Date
- 2025-07-11
- Lead Sponsor
- Shirley Ryan AbilityLab
- Target Recruit Count
- 20
- Registration Number
- NCT07061691
- Locations
- 🇺🇸
Shirley Ryan AbilityLab, Chicago, Illinois, United States
Neuromusculoskeletal Interface for Bionic Arms
- Conditions
- AmputationAmputation, TraumaticAmputation, SurgicalUpper Limb Amputation Above Elbow (Injury)
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- Shirley Ryan AbilityLab
- Target Recruit Count
- 12
- Registration Number
- NCT07032753
- Locations
- 🇺🇸
Shirley Ryan Abilitylab, Chicago, Illinois, United States
Pilot Remote Therapeutic Monitoring in Cancer Patients
- Conditions
- Cancer
- First Posted Date
- 2025-06-05
- Last Posted Date
- 2025-06-05
- Lead Sponsor
- Shirley Ryan AbilityLab
- Target Recruit Count
- 25
- Registration Number
- NCT07007039
- Locations
- 🇺🇸
Shirley Ryan AbilityLab, Chicago, Illinois, United States
Lower Limb ExoNET: Development and Evaluation for Gait Assistance With Stroke Survivors
- Conditions
- Healthy
- First Posted Date
- 2025-05-31
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- Shirley Ryan AbilityLab
- Target Recruit Count
- 20
- Registration Number
- NCT06999213
Wearable Sensors to Detect Atypical Muscle Activation in Young Infants
- Conditions
- Neuromuscular DisordersMotor DevelopmentMuscle Tone
- First Posted Date
- 2025-05-14
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Shirley Ryan AbilityLab
- Target Recruit Count
- 40
- Registration Number
- NCT06970522
- Locations
- 🇺🇸
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
🇺🇸Shirley Ryan AbilityLab, Chicago, Illinois, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 33
- Next
News
NervGen Pharma to Present Phase 1b/2a Trial of NVG-291 for Spinal Cord Injury at Upcoming Investor Event
NervGen Pharma will host a virtual investor event on April 9, 2025, featuring key opinion leaders to discuss the unmet medical needs and treatment landscape for spinal cord injury patients.